Optain
Company Overview
Optain is a global medical device and software company specializing in AI-powered healthcare solutions with a focus on non-invasive retinal screening technologies to detect eye diseases and cardiovascular conditions.
Mission and Vision
Optain envisions a future where early detection of chronic diseases is accessible to everyone, utilizing AI-driven oculomics to provide fast, accurate, and affordable retinal screening to improve patient care and clinical outcomes globally.
Products and Technology
They offer AI-enabled Software as a Medical Device (SaMD) combined with a portable automatic fundus camera as a turnkey solution to capture and analyze retinal images for conditions including glaucoma, diabetic retinopathy, age-related macular degeneration, and cardiovascular disease.
Leadership and Team
The company is led by a team of clinicians, scientists, and business leaders including co-founders and executives such as Jeff Dunkel (CEO), Mingguang He MD, PhD (Chief Medical Officer), and others with extensive expertise in medical technology, AI, and healthcare innovation.
Social Impact
Optain aims to democratize access to specialized disease screening, improve diagnosis speed, reduce missed diagnoses, and support efficient clinical decision-making to enhance healthcare quality worldwide.
Partners and Affiliates
Optain is backed by prominent researchers, clinicians, and industry partners such as Northwell Health and Aegis Ventures.